Oncology Voice Network
Join to access to all OVN content. Join for Free
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
diagnostic breast cancer digital biomarker genetic testing advocacy

Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy

  • Oct 19th 2025
  • 26 mins
  • Labcorp Perspectives Oncology

Share This Article

Clips

View Media
Summary

Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.

In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs connects with Suzanne Garner, Senior Director of Strategic Partnerships at Outcomes4Me, to spotlight her remarkable journey as a breast cancer patient, advocate, and now leader in digital health. Suzanne shares her personal story, from an unexpected diagnosis and navigating overwhelming choices, to the pivotal discovery that empowered her to actively participate in her treatment decisions.

Together, they discuss the critical role of biomarker and genetic testing in shaping individualized treatment plans and the impact of patient-friendly technology, like the Outcomes4Me app, in driving health equity and expanding access to clinical trials. Learn how education, self-advocacy, and digital tools are changing the cancer care landscape, and why the partnership between patient and oncologist matters more than ever.

Tune in for hope, practical insights, and real-world tools for patients, providers, and caregivers alike.

Click for Source

Related Topics

See More Topics

Meet Our Innovation Partners

You May Also Like

Article
Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?
Partner Avatar Envision Pharma Group

Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?

May 9th • 5 mins • read
Article
Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China
OVN Avatar Qiyou Wu, Zhiwei Lian, Xin Wang, Hanchao Cheng, Jing Sun, Hui Yu, Gong Zhang, Fan Wu, Jian Liu and Chuanben Chen

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China

Jan 12th • 13 mins • read
Article
Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?
OVN Avatar Neil Carleton and Priscilla F. McAuliffe

Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?

Dec 1st • 4 mins • read
Article
Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study
OVN Avatar Min Jeong Kim, Hyo Jung Kim, Danbee Kang, Hee Kyung Ahn, Soo-Yong Shin, Juhee Cho, Yeon Hee Park,

Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study

Oct 9th • 4 mins • read
Press Release
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology
OVN Avatar Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard

Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology

Oct 26th • 30 mins • read
Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

May 12th • 5 mins • read

Explore OVN

Articles Expert-written insights
Browse Topics Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN